Isabelle Mahé on Reduced Dose Apixaban and Cancer-Associated VTE
Isabelle Mahé, Head of Internal Medicine, Louis Mourier Hospital, APHP, Paris Cité University, shared on LinkedIn:
”Just published in the Lancet Haematology
In this post-hoc analysis of the API-CAT Study, including patients with CAT receiving extended anticoagulant with apixaban.
- 4 clinical predictors were significantly associated with increased CRB risk : anaemia and/or thrombocytopenia, age ≥75, PE as the index event, and male sex.
- 3 of them are also significant predictors of MB
- Identified predictors are non modifiable
- No cancer-related predictors associated with increased CRB risk
- Associations are consistent across cancer sites
- No evidence of interaction with apixaban dose
To reach the publication.
To reach the Comment.
As a reminder, in CAT extended treatment NEJM
Reduced dose apixaban is non inferior to full-dose on VTE recurrence, and associated with a 25% reduction in the risk of CRB
To reach the publication: Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism. DOI 10.1056/NEJMoa2416112”
Read the full article here.
Article: Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
Authors: Isabelle Mahé, Marc Carrier, Didier Mayeur, Jean Chidiac, Eric Vicaut, Nicolas Falvo, Olivier Sanchez et al.
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 3, 2026, 17:12Matteo Foschi: Cancer Worsens Prognosis after Breakthrough Ischemic Stroke Despite Oral Anticoagulation
-
Mar 3, 2026, 17:04Shiny K Kajal: Therapeutic Apheresis Is Redefining the Clinical Scope of Transfusion Medicine
-
Mar 3, 2026, 16:58Non-Carrier Mothers of Inv22 Hemophilia A Patients Frequently Harbor Additional F8 Gene Rearrangements – JTH
-
Mar 3, 2026, 16:53Valentina Rossi: Addressing Inflammation and Immune Mechanisms in Cardiomyopathy Management
-
Mar 3, 2026, 16:45Emmanuel J Favaloro: New Publication on Artificial Intelligence in Thrombosis and Hemostasis in CCLM
-
Mar 3, 2026, 16:32Scott E. Smith: Why Hematology Research Is the True Leader of all Medical Disciplines
-
Mar 3, 2026, 16:21Tareq Abadl: Why HIV Antibodies Stay Positive Even When Viral Load Is Zero?
-
Mar 3, 2026, 16:12Mark Crowther Congratulates Mary Cushman on Her Appointment as ISTH President
-
Mar 3, 2026, 15:42Cheng-Hock Toh։ The Unrecognised Central Role of Hematology in Healthcare Design